Description: Lymph Node tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl₂, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Lymph node tissue array, 24 cases/48 cores, replacing LY481

Description: Human lymph node tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human lymph node tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated lymph node tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated lymph node tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Description: Normal lymph node tissue array, 30 cases/ 60 cores,

Description: Human Lymph Node Tissue Lysate

Description: Human lymph node tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lymph node tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lymph node tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lymph node tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Lymph node and tonsil tissue array, 12 cases/24 cores, replacing LY241g

Description: Lymph node and tonsil tissue array, 12 cases/24 cores (core size 1.5mm), replacing LY241h

Description: Lymphoma with lymph node tissue array, 12 cases/24 cores, replaced by T203d

Description: Lymphoma with lymph node tissue array, 12 cases/ 24 cores, replacing T203c

Description: Multiple organ lymph node tissue array, 80 cases/80 cores, replacing LN802

Description: Human Lymph Node Lysate Membrane Fraction

Description: Lymphoma and normal lymph node tissue array, 24 cases/72 cores